跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Hospira Mitoxantrone sterile concentarte injection 20mg/10mL vial. - TGA Drug Approval Details
Approvals
/
TGA
/
Hospira Mitoxantrone sterile concentarte injection 20mg/10mL vial.
Approved
STANDARD
Hospira Mitoxantrone sterile concentarte injection 20mg/10mL vial.
Hospira Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
0230e0b4e7a1cb4b
Company
Hospira Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
0230e0b4e7a1cb4b
Product Name
Hospira Mitoxantrone sterile concentarte injection 20mg/10mL vial.
Artg Id
104194
Artg Name
Hospira Mitoxantrone sterile concentarte injection 20mg/10mL vial.
Sponsor
Hospira Australia Pty Ltd
Company Detail Path
/organization/hospira-australia-pty-ltd
Artg Date
2004-06-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
0230e0b4e7a1cb4b
Type
Standard
Back to TGA Approvals
